New research shows GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, published in the peer-reviewed journal Thyroid, the official journal of the American Thyroid Association, found no evidence linking the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to an increased risk of thyroid cancer. What are GLP1-RAs? […]
#Semaglutide #Increase #Risk #Thyroid #Cancer
